Anti-monocyte cytoplasmic antibodies in granulomatous disease

Clinical Immunology and Immunopathology

Volumn 81, Issue 1, 1996, Pages 88-95

  Forde, Anne M ^a   Feighery, Conleth ^a   Jackson, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; SARCOIDOSIS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

EID: 0030271938     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0162     Document Type: Article

References (28)

1. 1. Goldschmeding, R., van der Schoot, C. E., ten Bokkel Huinink, D., Hack, C. E., van den Ende, M. E., Kallenberg, C. G. M., and von dem Borne, A. E. G. Kr., Wegener's Granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest. 84, 1577-1587, 1989.
2. 2. Niles, J. L., Mc Cluskey, R. T., Ahmad, M. F., and Arnaout, M. A., Wegener's Granulomatosis autoantigen is a novel neutrophil serine protease. Blood 74, 1888-1893, 1989.
3. 3. Lüdemann, J., Utecht, B., and Gross, W. L., Anti-neutrophil cytoplasm antibodies in Wegener's Granulomatosis recognize an elastinolytic enzyme. J. Exp. Med. 171, 357-362, 1990.
4. 4. Falk, R. J., and Jennette, J. C., Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N. Engl. J. Med. 318, 1651-1657, 1988.
5. 5. Schmitt, W. H., Csernok, E., Flesch, B. K., Hauschild, S., and Gross, W. L., Autoantibodies directed against lysozyme: A new target for anti-neutrophil cytoplasmic antibodies. Adv. Exp. Med. Biol. 336, 267-273, 1993.
6. 6. Lee, S. S., Lawton, W. M., and Chan, C. E., Antilactoferrin antibody in systemic lupus erythematosous. Br. J. Rheumatol. 31, 669-673, 1992.
7. 7. Halbwechs-Mecarelli, L., Nusbaum, P., Nöel, L. H., Reumaux, D., Erlinger, S., Grünfeld, J. P., and Lesavre, P., Antineutrophil cytoplasmic antibodies (ANCA) directed against Cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol. 90, 79-84, 1992.
8. 8. Moodie, F. D. L., Leaker, B., Cambridge, G., Totty, N. F., and Segal, A. W., Alpha-enolase: A novel autoantigen in ANCA positive vasculitis. Kid. Int. 43, 675-681, 1993.
9. 9. Zhao, M. H., Jones, S. J., and Lockwood, C. M., Bactericidal/ permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in vasculitis. Clin. Exp. Immunol. 99, 49-56, 1995.
10. 10. Kain, R., Matsui, K., Exner, M., Binder, S., Schaffner, G., Sommer, E., and Kerjaschki, D., A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: The lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J. Exp. Med. 181, 585-597, 1995.
11. 11. Niles, J. L., Value of tests for antineutrophil cytoplasmic antibodies in the diagnosis and treatment of vasculitis. Curr. Op. Rheumatol. 5, 18-24, 1993.
12. 12. Kallenberg, C. G. M., Mulder, A. H. L., and Cohen Tervaert, J. W., Antineutrophil cytoplasmic antibodies: A still growing class of autoantibodies in inflammatory disorders. Am. J. Med. 93, 675-682, 1992.
13. 13. Roos, D., and Dolman, K. M., Neutrophil involvement in inflammatory tissue damage. Netherlands J. Med. 36, 89-94, 1990.
14. 14. Kallenberg, C. G. M., Brouwer, E., Mulder, A. H. L., Stegeman, C. A., Weening, J. J., and Cohen Tervaert, J. W., ANCA-patho-physiology revisited. Clin. Exp. Immunol. 100, 1-3, 1995.
15. 15. Van der Woulde, F. J., Rasmussen, N., Lobattos, S., Wiik, A., Permin, H., van Es, L. A., van der Giessen, M., and van der Hem, G. K., Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker for disease activity in Wegener's granulomatosis. Lancet 2, 425-429, 1985.
16. 16. Chandrasoma, P., and Taylor, C. R. (Eds.), Chronic inflammation. In "Concise Pathology," pp. 69-77, Appleton and Lange, Connecticut, 1995.
17. 17. Boyum, A., Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21(Suppl. 97), 77-89, 1968.
18. 18. Pharmacia, Coupling gels for ligand immobilisation. In "Affinity chromatography, Principles and Methods," Pharmacia, Sweden, 1986.
19. 19. Wiik, A., Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 97(Suppl. 6), 12-13, 1989.
20. 20. Hagen, E. C., Andrassy, K., Csernok, E., Daha, M. R., Gaskin, G., Gross, W., Lesavre, P., Lüdemann, J., Pusey, C. D., Rasmussen, N., Savage, C. O. S., Wiik, A., and van der Woude, F. J., The value of indirect immunofluorescence and solid phase techniques for ANCA detection. J. Immunol. Methods 159, 1-16, 1993.
21. 21. Csernok, E., Lüdemann, J., Gross, W. L., and Bainton, D. F., Ultrastructural localization of proteinase 3 the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137, 1113-1120, 1990.
22. 22. Saxon, A., Shanahan, F., Landers, C., Ganz, T., and Targan, S., A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J. Allergy Clin. Immunol. 8, 202-210, 1990.
23. 23. Cambridge, G., Rampton, D. S., Stevens, T. R. J., Mc Carthy, D. A., Kamm, M., and Leaker, B., Anti-neutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 33, 668-674, 1992.
24. 24. Hardarson, S., LaBrecque, D. R., Mitros, F. A., Neil, G. A., and Goeken, J. A., Antineutrophil cytoplasmic antibody in inflammatory boowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Am. J. Clin. Pathol. 99, 277-281, 1993.
25. 25. Hough, D. W., Miller, N. I., and Maddison, P. J., Effects of antinuclear autoantibodies on RNA polymerase. Immunol. Lett. 6, 123-127, 1983.
26. 26. Enzymes as autoantigens. Lancet 339, 779-780, 1992. [Editorial]
27. 27. Van der Wiel, B. A., Dolman, K. M., Van der Meer-Gerritsen, C. H., Hack, C. E., Von dem Borne, A. E. G. Kr., and Goldschmeding, R., Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin. Exp. Immunol. 90, 409-414, 1992.
28. 28. Daouk, G. H., Palsson, R., and Arnaout, M. A., Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kid. Int. 47, 1528-1536, 1995.